Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression
Authors
Keywords
Hypercholesterolemia, Gypenoside LVI, PCSK9, LDLR, SREBP-2
Journal
PHYTOMEDICINE
Volume 91, Issue -, Pages 153688
Publisher
Elsevier BV
Online
2021-07-30
DOI
10.1016/j.phymed.2021.153688
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis
- (2020) Hongshan Li et al. Nutrition & Metabolism
- 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2020) Francois Mach et al. RUSSIAN JOURNAL OF CARDIOLOGY
- Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents
- (2019) C Macchi et al. European Journal of Preventive Cardiology
- Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
- (2019) Dongdong Wang et al. PHARMACOLOGICAL REVIEWS
- Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression
- (2019) Xiaoqing Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Gypenoside LVI attenuates foam cell formation by promoting cholesterol export and inhibiting inflammation response
- (2018) Chun-Yan Shen et al. Journal of Functional Foods
- Regulation of PCSK9 by nutraceuticals
- (2017) Amir Abbas Momtazi et al. PHARMACOLOGICAL RESEARCH
- Revisiting Outcomes–Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab
- (2017) Inmaculada Hernandez JAMA Internal Medicine
- Stress-induced upregulation of VLDL receptor alters Wnt-signaling in neurons
- (2016) Kai Kysenius et al. EXPERIMENTAL CELL RESEARCH
- Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
- (2015) Gregory A. Roth et al. CIRCULATION
- Metabolite profiling of gypenoside LVI in rat after oral and intravenous administration
- (2014) Dao-Jin Chen et al. ARCHIVES OF PHARMACAL RESEARCH
- Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment
- (2014) Christian Werner et al. VASCULAR PHARMACOLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New lipid and lipoprotein targets for the treatment of cardiometabolic diseases
- (2012) Stanley L. Hazen JOURNAL OF LIPID RESEARCH
- SILAC-based quantitative proteomic analysis of gastric cancer secretome
- (2012) Arivusudar Marimuthu et al. Proteomics Clinical Applications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More